Contineum Therapeutics

CTNMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$504.123 M

$13.40 -1.11%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$60.0M

Loss-making

Shares outstanding

23,099,173

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#207KamadaKMDA$511.9M
#208Puma BiotechnologyPBYI$506.9M
#209Contineum TherapeuticsCTNM$504.1M
#210Prothena Corp PublicPRTA$461.5M
#211Turn TherapeuticsTTRX$455.5M

What if Contineum Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$803,643.27

Per share 59,973× higher

Bitcoin $1.74T

$46,294.59

Per share 3,455× higher

Nvidia $5.52T

$146,613.53

Per share 10,941× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Contineum Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.